Platform updates
Release notes, platform milestones, partner updates, and ecosystem announcements will be shared here.
Coming soon
Open-source ecosystem for in vitro and microphysiological systemsNews and Events
Follow PhysioVerse announcements, workshops, learning events, community calls, standards activities, and opportunities to participate.
Coming soon
This page is prepared for announcements, events, release notes, partner activities, training opportunities, and community updates as the platform moves forward.
Release notes, platform milestones, partner updates, and ecosystem announcements will be shared here.
Coming soonTraining sessions, standards exchange meetings, contributor workshops, and community events will be posted as dates are finalized.
Coming soonOpportunities for contributors, tool developers, curators, reviewers, partners, and institutions will be listed here.
Coming soonShare updates
Contact the team about community workshops, dataset releases, standards exchange activities, partner opportunities, and training events.
Standards and manufacturing partners
Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.
The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.
The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.